Teresa Amaral
University of Tübingen, Germany
Teresa Amaral, MD, PhD, is the Head of the Skin Cancer Clinical Trials Center at the University of Tübingen, Germany. Her research focuses on predictive biomarkers for systemic therapy in advanced melanoma and prognostic biomarkers in early-stage melanoma. She serves as Chair of the ESMO Leadership Development Committee and is a member of the ESMO Melanoma and Other Skin Tumours Faculty.
